Data Mining of Gene Arrays for Biomarkers of Survival in Ovarian Cancer

The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this applies to the 7000 new cases diagnosed yearly in the UK. Stratification of patients with this heterogeneous disease, based on active molecular pathways, would aid a targeted treatment improving the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Coveney, Clare, Boocock, David J., Rees, Robert C., Deen, Suha, Ball, Graham R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996375/
https://www.ncbi.nlm.nih.gov/pubmed/27600227
http://dx.doi.org/10.3390/microarrays4030324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996375/
https://www.ncbi.nlm.nih.gov/pubmed/27600227
http://dx.doi.org/10.3390/microarrays4030324

Ejemplares similares